512 related articles for article (PubMed ID: 15953432)
1. Incidence of cytomegalovirus (CMV) retinitis in second eyes of patients with the acquired immune deficiency syndrome and unilateral CMV retinitis.
Kempen JH; Jabs DA; Wilson LA; Dunn JP; West SK
Am J Ophthalmol; 2005 Jun; 139(6):1028-34. PubMed ID: 15953432
[TBL] [Abstract][Full Text] [Related]
2. Characteristics of untreated AIDS-related cytomegalovirus retinitis. II. Findings in the era of highly active antiretroviral therapy (1997 to 2000).
Holland GN; Vaudaux JD; Shiramizu KM; Yu F; Goldenberg DT; Gupta A; Carlson M; Read RW; Novack RD; Kuppermann BD;
Am J Ophthalmol; 2008 Jan; 145(1):12-22. PubMed ID: 18154751
[TBL] [Abstract][Full Text] [Related]
3. Characterization of reactivation of cytomegalovirus retinitis in patients healed after treatment with highly active antiretroviral therapy.
Song MK; Karavellas MP; MacDonald JC; Plummer DJ; Freeman WR
Retina; 2000; 20(2):151-5. PubMed ID: 10783947
[TBL] [Abstract][Full Text] [Related]
4. The effect of cytomegalovirus retinitis on the quality of life of patients with AIDS in the era of highly active antiretroviral therapy.
Kempen JH; Martin BK; Wu AW; Barron B; Thorne JE; Jabs DA;
Ophthalmology; 2003 May; 110(5):987-95. PubMed ID: 12750102
[TBL] [Abstract][Full Text] [Related]
5. Quantitative cytomegalovirus DNA level in the blood and its relationship to cytomegalovirus retinitis in patients with acquired immune deficiency syndrome.
Tufail A; Moe AA; Miller MJ; Wagar EA; Bruckner DA; Holland GN
Ophthalmology; 1999 Jan; 106(1):133-41. PubMed ID: 9917794
[TBL] [Abstract][Full Text] [Related]
6. Clinical characteristics and outcomes of cytomegalovirus retinitis in persons without human immunodeficiency virus infection.
Kuo IC; Kempen JH; Dunn JP; Vogelsang G; Jabs DA
Am J Ophthalmol; 2004 Sep; 138(3):338-46. PubMed ID: 15364214
[TBL] [Abstract][Full Text] [Related]
7. Effect of combination antiretroviral therapy on cytomegalovirus retinitis.
Banker AS; Patel A
Indian J Ophthalmol; 2002 Mar; 50(1):29-33. PubMed ID: 12090084
[TBL] [Abstract][Full Text] [Related]
8. Cytomegalovirus retinitis in the era of highly active antiretroviral therapy.
Kedhar SR; Jabs DA
Herpes; 2007 Dec; 14(3):66-71. PubMed ID: 18371289
[TBL] [Abstract][Full Text] [Related]
9. Course of cytomegalovirus retinitis in the era of highly active antiretroviral therapy: 2. Second eye involvement and retinal detachment.
Jabs DA; Van Natta ML; Thorne JE; Weinberg DV; Meredith TA; Kuppermann BD; Sepkowitz K; Li HK;
Ophthalmology; 2004 Dec; 111(12):2232-9. PubMed ID: 15582079
[TBL] [Abstract][Full Text] [Related]
10. Incidence of and risk factors for visual acuity loss among patients with AIDS and cytomegalovirus retinitis in the era of highly active antiretroviral therapy.
Thorne JE; Jabs DA; Kempen JH; Holbrook JT; Nichols C; Meinert CL;
Ophthalmology; 2006 Aug; 113(8):1432-40. PubMed ID: 16766032
[TBL] [Abstract][Full Text] [Related]
11. Discontinuation of maintenance therapy in patients with quiescent cytomegalovirus retinitis and elevated CD4+ counts.
Vrabec TR; Baldassano VF; Whitcup SM
Ophthalmology; 1998 Jul; 105(7):1259-64. PubMed ID: 9663231
[TBL] [Abstract][Full Text] [Related]
12. Change over time in incidence of ganciclovir resistance in patients with cytomegalovirus retinitis.
Martin BK; Ricks MO; Forman MS; Jabs DA;
Clin Infect Dis; 2007 Apr; 44(7):1001-8. PubMed ID: 17342657
[TBL] [Abstract][Full Text] [Related]
13. Risk of immune recovery uveitis in patients with AIDS and cytomegalovirus retinitis.
Kempen JH; Min YI; Freeman WR; Holland GN; Friedberg DN; Dieterich DT; Jabs DA;
Ophthalmology; 2006 Apr; 113(4):684-94. PubMed ID: 16581429
[TBL] [Abstract][Full Text] [Related]
14. Cytomegalovirus (CMV)-specific CD4+ T lymphocyte immune function in long-term survivors of AIDS-related CMV end-organ disease who are receiving potent antiretroviral therapy.
Jacobson MA; Schrier R; McCune JM; Torriani FJ; Holland GN; O'Donnell JJ; Freeman WR; Bredt BM
J Infect Dis; 2001 May; 183(9):1399-404. PubMed ID: 11294673
[TBL] [Abstract][Full Text] [Related]
15. Causes of visual acuity loss among patients with AIDS and cytomegalovirus retinitis in the era of highly active antiretroviral therapy.
Thorne JE; Jabs DA; Kempen JH; Holbrook JT; Nichols C; Meinert CL;
Ophthalmology; 2006 Aug; 113(8):1441-5. PubMed ID: 16781775
[TBL] [Abstract][Full Text] [Related]
16. Course of cytomegalovirus retinitis in the era of highly active antiretroviral therapy: 1. Retinitis progression.
Jabs DA; Van Natta ML; Thorne JE; Weinberg DV; Meredith TA; Kuppermann BD; Sepkowitz K; Li HK;
Ophthalmology; 2004 Dec; 111(12):2224-31. PubMed ID: 15582078
[TBL] [Abstract][Full Text] [Related]
17. Loss of cytomegalovirus-specific CD4+ T cell responses in human immunodeficiency virus type 1-infected patients with high CD4+ T cell counts and recurrent retinitis.
Komanduri KV; Feinberg J; Hutchins RK; Frame RD; Schmidt DK; Viswanathan MN; Lalezari JP; McCune JM
J Infect Dis; 2001 Apr; 183(8):1285-9. PubMed ID: 11262214
[TBL] [Abstract][Full Text] [Related]
18. Association between cytomegalovirus-specific reactivity of T cell subsets and development of cytomegalovirus retinitis in patients with acquired immunodeficiency syndrome.
Hsieh SM; Pan SC; Hung CC; Tsai HC; Chen MY; Chang SC
J Infect Dis; 2001 Dec; 184(11):1386-91. PubMed ID: 11709780
[TBL] [Abstract][Full Text] [Related]
19. Outcomes associated with ganciclovir implants in patients with AIDS-related cytomegalovirus retinitis.
Kappel PJ; Charonis AC; Holland GN; Narayanan R; Kulkarni AD; Yu F; Boyer DS; Engstrom RE; Kuppermann BD;
Ophthalmology; 2006 Apr; 113(4):683.e1-8. PubMed ID: 16581428
[TBL] [Abstract][Full Text] [Related]
20. Mortality risk for patients with cytomegalovirus retinitis and acquired immune deficiency syndrome.
Kempen JH; Jabs DA; Wilson LA; Dunn JP; West SK; Tonascia J
Clin Infect Dis; 2003 Nov; 37(10):1365-73. PubMed ID: 14583871
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]